News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Robert F. Shaffer

Advertisement

Robert F. Shaffer is an attorney at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.

Articles by Robert F. Shaffer

Combination Products: Regulatory and Patent Issues You Should Consider Now

ByShana K. Cyr,Paula Miller,Deborah M. Herzfeld,Robert F. Shaffer
February 23rd 2017

The authors discuss regulatory and patent issues with combination products.

Advertisement

Latest Updated Articles

  • Combination Products: Regulatory and Patent Issues You Should Consider Now
    Combination Products: Regulatory and Patent Issues You Should Consider Now

    Published: February 23rd 2017 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs

2

The Shift from Containment to Protection: Packaging Trends Impacting Pharma

3

West Launches New Prefillable Syringe System that Streamlines Biologic Delivery

4

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

5

FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us